Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/1
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai)
Description: Subject matter under Class 424 definition which contains a designated organic active ingredient, e.g., coal tar, coal tar oil, etc.










Sub-classes under this class:

Class Number Class Name Patents
514/ Heterocyclic carbon cpmpounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 0
514/149 Azoxy doai 54
514/150 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide doai 288
514/152 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) doai 329
514/155 Para-n-benzene - sulfoxy-n containing doai, and said benzene ring is not part of a polycyclo ring system 77
514/159 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai 380
514/167 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin d, etc.) doai 707
514/169 Cyclopentanohydrophenanthrene ring system doai 611
514/183 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai 2,142
514/2 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai 7,690
514/22 Lignin or derivative doai 51
514/23 Carbohydrate (i.e., saccharide radical containing) doai 1,811
514/476 N-c(=x)x containing (x is chalcogen) doai 179
514/492 Heavy metal containing doai 681
514/506 Ester doai 329
514/553 Radical -xh acid, or anhydride, acid halide or salt thereof (x is chalcogen) doai 295
514/579 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso doai 301
514/63 Silicon containing doai 1,033
514/64 Boron containing doai 255
514/65 Pyrethrum plant derived material or plant derived rotenone compound containing doai 96
514/675 Ketone doai 216
514/693 Aldehyde doai 172
514/706 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.) 247
514/714 Peroxide doai 141
514/715 Ether doai 140
514/724 C-o-group (e.g., alcohol, alcoholate, etc.) doai 587
514/740 Nitrogen containing compound doai 149
514/743 Halogenated hydrocarbon doai 80
514/75 Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai 320
514/762 Hydrocarbon doai 190


Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
8093217 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers Jan. 10, 2012
8088737 Compositions, methods and kits relating to Her-2 cleavage Jan. 3, 2012
8084250 Defensin-antigen fusion proteins Dec. 27, 2011
8084413 Urocortin-III and uses thereof Dec. 27, 2011
8080534 Targeting PAX2 for the treatment of breast cancer Dec. 20, 2011
8080515 Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein Dec. 20, 2011
8071532 Use of C1 inhibitor for the prevention of ischemia-reperfusion injury Dec. 6, 2011
8071533 Compositions and methods for modulating store-operated calcium entry Dec. 6, 2011
8071534 Material for facilitating thermal treatments of biological tissues and method of energy targeting leading to thermal treatment of biological tissues Dec. 6, 2011
8067358 Triple-action remedy for removing toxic oils from skin with simultaneous soothing and healing Nov. 29, 2011
8067357 Annexin derivatives suitable for pretargeting in therapy and diagnosis Nov. 29, 2011
8067356 High fibre high calorie liquid or powdered nutritional composition Nov. 29, 2011
8067189 Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators by measuring the level of collagen type IV Nov. 29, 2011
8067022 Therapeutic inhibitor of vascular smooth muscle cells Nov. 29, 2011
8066997 Modulation of activity of neurotrophins Nov. 29, 2011
8058225 Proteins for use in human and animal Staphylococcus infections Nov. 15, 2011
8058249 Immunostimulatory nucleic acid molecules Nov. 15, 2011
8048844 Preventing airway mucus production by administration of EGF-R antagonists Nov. 1, 2011
8043831 Therapeutic agents comprising pro-apoptotic proteins Oct. 25, 2011
8043601 Cyclic azapeptides as integrin markers Oct. 25, 2011
8039261 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis Oct. 18, 2011
8030286 Methods and means for increasing resistance to cell damage Oct. 4, 2011
8026212 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretatgogues Sep. 27, 2011
8021665 Identification and application of antibiotic synergy Sep. 20, 2011
8017595 Methods of drug delivery using sulphated chitinous polymers Sep. 13, 2011
8017574 Methods of preparing pharmaceutical compositions comprising GPR119 agonists having the effect of glucose-dependent insulinotropic peptide secretagogues Sep. 13, 2011
8003621 Drug carriers Aug. 23, 2011
7998685 Methods of identifying candidate compounds of the human G protein-coupled receptor, GPR50, as modulators of body mass or adiposity Aug. 16, 2011
7998922 Process for treating fibroses with biocompatible polymer Aug. 16, 2011
7998934 PAI-2 conjugates for the treatment and imaging of cancer Aug. 16, 2011
7994113 .beta.GBP, compositions comprising .beta.GBP, and related methods and uses thereof Aug. 9, 2011
7989208 Gamma secretase notch biomarkers Aug. 2, 2011
7989002 High gloss gel-based lipstick Aug. 2, 2011
7985726 .psi..epsilon.RACK peptide composition and method for protection against tissue damage due to ischemia Jul. 26, 2011
7981857 Cerberus/coco derivatives and uses thereof Jul. 19, 2011
7973005 Alpha-1 antitrypsin for treating exacerbation episodes of pulmonary diseases Jul. 5, 2011
7964640 Oligomers of straight-chain and unbranched fatty acids and drugs containing these Jun. 21, 2011
7964554 Polypeptide that binds anti-histone H1 antibody Jun. 21, 2011
7964346 Mammalian genes involved in infection Jun. 21, 2011
7959907 Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide Jun. 14, 2011
7960346 Tumor cytotoxicity induced by modulators of the CXCR4 receptor Jun. 14, 2011
7960347 Matrix protein compositions for induction of apoptosis Jun. 14, 2011
7960364 Methods for modulating the efficacy of nucleic acid based therapies Jun. 14, 2011
7951396 Preparation of nanoliposome-encapsulating proteins and protein-encapsulated nanoliposome May. 31, 2011
7947652 Compositions and methods for modulating PGC-1.alpha. to treat huntington's disease May. 24, 2011
7947278 Methods of modulating angiogenesis May. 24, 2011
7939489 Oil absorbent topical compositions and methods for using same May. 10, 2011
7928072 Multimeric constructs Apr. 19, 2011
7923429 Treatment for CD5.sup.+ B cell lymphoma Apr. 12, 2011
7919453 Dosage cap assembly for an applicator Apr. 5, 2011

1 2 3 4 5 6 7 8 9 10 11 12 13 14










 
 
  Recently Added Patents
Distributive data capture
Control system for an internal combustion engine
Resist composition and method for producing resist pattern
VEGF-specific capture agents, compositions, and methods of using and making
High conductive water-based silver ink
Rapid glycopeptide optimization via neoglycosylation
Bundled flexible cable with water resistant structure
  Randomly Featured Patents
Laser biostimulator for veterinary and human use
Optical films
Method for the transmission of multimedia data utilizing a signaling signal in a telecommunications network
Sound shield for a surface cleaning apparatus
Archery bow
Bluetooth headset
Receptor that binds IL-17
Ink feed connecting member
Scanner motor
Data storage system with a removable backplane having a array of disk drives